The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial.
 
Sebastian Stintzing
Honoraria - Amgen; Bayer; Lilly; Merck KGaA; Roche; Sanofi; Sirtex Medical
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Lilly; Merck KGaA; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; Merck KGaA; Roche; Sanofi; Sirtex Medical
 
Pratyaksha Wirapati
No Relationships to Disclose
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Pfizer; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Daniel Neureiter
No Relationships to Disclose
 
Ludwig Fischer von Weikersthal
No Relationships to Disclose
 
Thomas Decker
No Relationships to Disclose
 
Alexander Kiani
No Relationships to Disclose
 
Ursula Vehling-Kaiser
No Relationships to Disclose
 
Salah-Eddin Al-Batran
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Roche; SERVIER
Speakers' Bureau - Celgene; Lilly; Nordic Bioscience; Roche
Research Funding - Celgene; Hospira; Lilly; Medac; Novartis; Roche Pharma AG; Vifor Pharma
 
Tobias Heintges
No Relationships to Disclose
 
Christoph Kahl
No Relationships to Disclose
 
Frank Kullmann
No Relationships to Disclose
 
Markus H. Moehler
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly/ImClone; Merck Serono; MSD Oncology; Roche/Genentech; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck Serono; MSD; Nordic Group; Pfizer; Roche; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Jennerex (Inst); Leap Therapeutics (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Amgen; ASCO; Bayer; German Cancer Society; Merck Serono; Nordic Bioscience; Roche
 
Werner Scheithauer
No Relationships to Disclose
 
Swantje Held
No Relationships to Disclose
 
Dominik Paul Modest
Honoraria - Amgen; Bayer; Merck Serono; Roche
Consulting or Advisory Role - Amgen; Bayer; Merck Serono
Research Funding - Amgen (Inst); Merck Serono (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Sanofi
 
Andreas Jung
No Relationships to Disclose
 
Thomas Kirchner
No Relationships to Disclose
 
Sabine Tejpar
Honoraria - Merck Serono; Regeneron
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Merck Serono; Regeneron; Roche/Genentech
Speakers' Bureau - Merck Serono; Roche; Sanofi
Research Funding - Merck Serono (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Merck Serono; Roche; Sanofi
 
Volker Heinemann
Honoraria - Amgen; Baxalta; Celgene; Merck; Roche; Sanofi; Sirtex Medical
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Merck; Roche; Sanofi; Sirtex Medical
Research Funding - Amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); IntegraGen (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Sirtex Medical (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Amgen; Baxalta; Merck; Roche; Sirtex Medical